Hillrom and Welch Allyn are a part of Baxter.
DOXIL (doxorubicin hydrochloride liposome injection), 20mg / 10mL (2mg / mL) Single-Dose Vial. (New Product Code: 2321B0132)
Item Number: 2321B0132
GTIN:
00303389667018
GTIN-CS:
50303389667013
Added to Your Cart
Product Availability by Store Location
Hours
DOXIL (doxorubicin hydrochloride liposome injection), 20mg / 10mL (2mg / mL) Single-Dose Glass Vial. see link below for Full Prescribing Information, including Boxed Warning. NDC 0338-9667-01
Product Characteristics
| Trademark | Baxter, Doxil, and Stealth are trademarks of Baxter International Inc. or its subsidiaries. |
| Volume | 10.0 ml |
| DEHP Free | Yes |
| PVC Free | Yes |
| Latex Free | Yes |
| Shelf Life from Manufacture | 20 months |
| Container Type | Glass Vial |
| Containes Preservative | No |
| Dosage Form | Liquid |
| Polyethlene Lined | No |
| Protect From Light | No |
| Rx Only | Yes |
| Storage Recommendations | Refrigerate unopened vials of DOXIL (doxorubicin hydrochloride liposome injection) at 2°C- 8°C (36°F- 46°F). Do not freeze. Discard unused portion. Follow applicable special handling and disposal procedures for cytotoxic drugs. |
| Strength | 20mg / 10mL |
Carton
| Units per Case | 1.0 |
| Carton Weight | 0.09 lb. |
| Carton Length | 1.73 in. |
| Carton Width | 1.73 in. |
| Carton Height | 3.27 in. |
| Carton Volume | 9.79 ci |
Reimbursement Information
| HCPCS Code | HCPCS Description |
| Q2050 | Doxorubicin Injection 10mg |
| Medication Delivery Reimbursement Hotline | 888-338-0001 |
Information Source : CMS
Disclaimer:The coverage, coding, and payment information included in this guide has been compiled from various resources for informational use as a tool to assist providers with reimbursement issues. This information is current as of 3/31/2008; however this information is subject to change and should not be construed as legal advice. Providers should exercise independent clinical judgment when selecting codes and submitting claims to accurately reflect services rendered to individual patients. Baxter Healthcare Corporation does not guarantee success in obtaining insurance payments. Providers are encouraged to contact third-party payors for specific information on their coverage, coding, and payment policies.
Disclaimer:The coverage, coding, and payment information included in this guide has been compiled from various resources for informational use as a tool to assist providers with reimbursement issues. This information is current as of 3/31/2008; however this information is subject to change and should not be construed as legal advice. Providers should exercise independent clinical judgment when selecting codes and submitting claims to accurately reflect services rendered to individual patients. Baxter Healthcare Corporation does not guarantee success in obtaining insurance payments. Providers are encouraged to contact third-party payors for specific information on their coverage, coding, and payment policies.
| Item Number | 2321B0132 |
| Sales Unit | box |
| GTIN | 00303389667018 |
| GTIN-CS | 50303389667013 |
| National Drug Code | 0338966701 |
Documentation
203052r1
Do you want to save the changes before you leave?
We are processing your request, do not go back, refresh or close the window.
Please wait...
Please wait...


